<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Ophthalmol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Ophthalmology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Ophthalmol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2674-0826</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fopht.2025.1749411</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>General Commentary</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Commentary: Synergistic AI-resident approach achieves superior diagnostic accuracy in tertiary ophthalmic care for glaucoma and retinal disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Williams-Gaona</surname><given-names>Kevin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Corro</surname><given-names>Rosa</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3285764/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Caja de Seguro Social (CSS) Dr. Hugo Spadafora</institution>, <city>Col&#xf3;n</city>,&#xa0;<country country="pa">Panama</country></aff>
<aff id="aff2"><label>2</label><institution>Department of Research, Mayo Clinic Florida</institution>, <city>Jacksonville</city>, <state>FL</state>,&#xa0;<country country="us">United States</country></aff>
<author-notes>
<corresp id="c001"><label>*</label>Correspondence: Rosa Corro, <email xlink:href="mailto:rosaacorro@gmail.com">rosaacorro@gmail.com</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2025-12-19">
<day>19</day>
<month>12</month>
<year>2025</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2025</year>
</pub-date>
<volume>5</volume>
<elocation-id>1749411</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>11</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>12</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>02</day>
<month>12</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Williams-Gaona and Corro.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Williams-Gaona and Corro</copyright-holder>
<license>
<ali:license_ref start_date="2025-12-19">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.3389/fopht.2025.1581212" journal-id="Front Ophthalmol" journal-id-type="nlm-ta">A Commentary on: 
<article-title>Synergistic AI-resident approach achieves superior diagnostic accuracy in tertiary ophthalmic care for glaucoma and retinal disease</article-title> By Camacho-Garc&#xed;a-Forment&#xed; D, Bayl&#xf3;n-V&#xe1;zquez G, Arriozola-Rodr&#xed;guez K, Avalos-Ramirez E, Hartleben-Matkin C, Valdez-Flores H, Hodelin-Fuentes D and Noriega A (2025) <italic>Front. Ophthalmol.</italic> 5:1581212. doi:&#xa0;<object-id>10.3389/fopht.2025.1581212</object-id>
</related-article>
<kwd-group>
<kwd>artificial intelligence</kwd>
<kwd>clinical training</kwd>
<kwd>diagnostic workflow</kwd>
<kwd>medical education</kwd>
<kwd>ophthalmology</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for work and/or its publication.</funding-statement>
</funding-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="3"/>
<page-count count="2"/>
<word-count count="738"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>New Technologies in Ophthalmology</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<p>Camacho-Garc&#xed;a-Forment&#xed; et&#xa0;al. present an impressive demonstration of how a synergistic collaboration between artificial intelligence systems and resident physicians can improve diagnostic accuracy in glaucoma and retinal disease. Not only do they show that an AI-resident partnership can outperform either one alone, they also demonstrate something that many groups struggle to capture: how these systems behave in a real tertiary-care environment. Anyone who has worked in a busy ophthalmology service knows that elegant results on paper are one thing, and making them coexist with high patient load, mixed pathology, and time pressure is another. Their team managed both.</p>
<p>Even though the combined approach was the top performer, the study also shows that AI on its own outperformed first-year residents across several key measures, including higher accuracy in glaucoma suspect classification (88.6% vs. 82.9%) and much higher sensitivity for retinal disease (76% vs. 52%, and 100% for high-risk findings). AI&#x2019;s CDR estimates also tracked more closely with expert measurements than those of residents (r = 0.728 vs. 0.538), although the system could only evaluate CDR in 61.6% of patients because of image-quality issues. That detail matters: even when an algorithm performs well, real-world imaging is variable, and someone still needs to handle the cases it cannot process.</p>
<p>As we read through their results, a central question emerged. We talk a lot about &#x201c;human in the loop&#x201d; AI, and it&#x2019;s usually framed as a reassuring idea. The algorithm assists, but the clinician remains in control. That logic works today, when clinicians have years of pattern recognition behind them. But what happens when the human entering the loop has had fewer chances to build the very skills the loop depends on?</p>
<p>Ophthalmology is built on repetition. Residents grow by seeing normal variants, borderline OCTs, unusual discs, cases that fooled everyone for a moment, and even the occasional false alarm. These encounters are not random; they form the &#x201c;texture&#x201d; of training. And with an incorporated system of AI reaching 76% sensitivity overall and up to 100% for high-risk findings, the educational risk may shift toward reduced cognitive effort. The stakes of being wrong feel lower, and it becomes easier for trainees to lean on the model&#x2019;s output. That subtle shift is enough to reshape how clinical judgment develops.</p>
<p>That picture shifts even more if these systems begin to be used simultaneously or as a first-pass screening tool, in favor of the higher accuracy demonstrated by a synergistic approach. Current discussions about glaucoma care already consider AI-based screening and triage as likely components of routine workflows (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). For example, if AI becomes very reliable at identifying early glaucoma or prioritizing retinal findings and begins filtering or labeling before a trainee even looks at an image, residents may start encountering a narrower slice of disease, mostly the ambiguous or the highly complex. That sounds ideal at first, but exposure to the full spectrum is what builds confidence in calling something &#x201c;normal&#x201d; or &#x201c;stable,&#x201d; which is just as important as diagnosing pathology. And when AI makes the right call 90% of the time, trainees might, without meaning to, start deferring to the algorithm instead of forming their own mental map first.</p>
<p>Of course, this future is not inevitable. There is room for deliberate design. AI systems could be built with &#x201c;teaching modes&#x201d; that intentionally route uncertain or instructive cases to trainees before any automatic labeling. They could generate sets of high-yield comparisons, or highlight regions of low model confidence so residents learn where humans still outperform machines. Early work in explainable AI and recent discussions on supervised integration suggest that these kinds of interactions could become a genuine educational asset (<xref ref-type="bibr" rid="B3">3</xref>).</p>
<p>But none of that will happen if training is not part of the AI conversation from the beginning. The article by Camacho-Garc&#xed;a-Forment&#xed; et&#xa0;al. shows how well AI can support clinical care right now. What we hope to add is that implementation planning should also consider how residents will grow inside these new systems. The &#x201c;human in the loop&#x201d; model only works if the human entering the loop is well prepared, and that preparation depends on protecting opportunities for independent clinical reasoning.</p>
<p>Their study opens the door to improving accuracy and workflow efficiency. The next step is making sure the same progress strengthens, rather than narrows, the education of future ophthalmologists.</p>
</body>
<back>
<sec id="s1" sec-type="author-contributions">
<title>Author contributions</title>
<p>KW-G: Conceptualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. RC: Conceptualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p></sec>
<sec id="s3" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
<sec id="s4" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p></sec>
<sec id="s5" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Martucci</surname> <given-names>A</given-names></name>
<name><surname>Gallo Afflitto</surname> <given-names>G</given-names></name>
<name><surname>Pocobelli</surname> <given-names>G</given-names></name>
<name><surname>Aiello</surname> <given-names>F</given-names></name>
<name><surname>Mancino</surname> <given-names>R</given-names></name>
<name><surname>Nucci</surname> <given-names>C</given-names></name>
</person-group>. 
<article-title>Lights and Shadows on Artificial Intelligence in Glaucoma: Transforming Screening, Monitoring, and Prognosis</article-title>. <source>J Clin Med</source>. (<year>2025</year>) <volume>14</volume>:<elocation-id>2139</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/jcm14072139</pub-id>, PMID: <pub-id pub-id-type="pmid">40217589</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>My&#x15b;licka</surname> <given-names>A</given-names></name>
<name><surname>Wyro&#x15b;lak</surname> <given-names>A</given-names></name>
<name><surname>Milewski</surname> <given-names>M</given-names></name>
<name><surname>Misiuk-Hoj&#x142;o</surname> <given-names>M</given-names></name>
</person-group>. 
<article-title>The role of artificial intelligence in ophthalmology - brief review</article-title>. <source>Ophthalmol J</source>. (<year>2024</year>) <volume>9</volume>:<fpage>53</fpage>&#x2013;<lpage>60</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.5603/OJ.98905</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Heinke</surname> <given-names>A</given-names></name>
<name><surname>Radgoudarzi</surname> <given-names>N</given-names></name>
<name><surname>Huang</surname> <given-names>BB</given-names></name>
<name><surname>Baxter</surname> <given-names>SL</given-names></name>
</person-group>. 
<article-title>A review of ophthalmology education in the era of generative artificial intelligence</article-title>. <source>Asia Pac J Ophthalmol (Phila).</source> (<year>2024</year>) <volume>13</volume>:<elocation-id>100089</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.apjo.2024.100089</pub-id>, PMID: <pub-id pub-id-type="pmid">39134176</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/338346">Michael Wormstone</ext-link>, The University of Nottingham Ningbo (China), China</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/258895">Alessio Martucci</ext-link>, University of Rome Tor Vergata, Italy</p></fn>
</fn-group>
</back>
</article>